'One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial' - author's response.
Journal
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Journal Volume
30
Journal Issue
11
ISSN
1469-0691
Date Issued
2024-11
Author(s)
Type
letter